Abstract
Herein we examine the effects of sodium benzoate and sodium phenylacetate on feeding and central serotonin turnover in a child with citrullinemia and in an animal model of congenital hyperammonemia, the ornithine transcarbamylase-deficient sparse-fur (spf/y) mouse. In the child, when the benzoate/phenylacetate dosage was increased from 200 to 375 mg/kg/day each, feeding decreased. There was an accumulation of benzoate and phenylacetate in blood and cerebrospinal fluid as well as an increased concentration of 5-hydroxyindoleacetic acid, a neurochemical marker for serotonin turnover, in cerebrospinal fluid. In the mouse, sodium benzoate had a biphasic effect on both plasma ammonium levels and brain serotonin turnover. Two percent oral benzoate was associated with an increase in ammonium level, while a 3% dose led to a decrease in ammonium. There was a similar effect on serotonin turnover noted in both the hyperammonemic spf/y and control CD-1/y mice. Sodium phenylacetate did not have a consistent effect on serotonin turnover. The mechanism by which benzoate increases brain serotonin turnover appears to involve competition with tryptophan for albumin binding sites. This results in increased free tryptophan in serum and brain. We speculate that some of the clinical symptoms of benzoate intoxication may be a consequence of altered serotonin turnover in the brain. We suggest that drug levels be monitored during therapy.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Batshaw, M., Hyman, S., Coyle, J. et al. Effect of Sodium Benzoate and Sodium Phenylacetate on Brain Serotonin Turnover in the Ornithine Transcarbamylase-Deficient Sparse-Fur Mouse. Pediatr Res 23, 368–374 (1988). https://doi.org/10.1203/00006450-198804000-00006
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-198804000-00006
This article is cited by
-
Evidence for forebrain cholinergic neuronal loss in congenital ornithine transcarbamylase deficiency
Metabolic Brain Disease (2000)
-
Ornithine transcarbamylase deficiency: Pathogenesis of the cerebral disorder and new prospects for therapy
Metabolic Brain Disease (1997)
-
Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency
Metabolic Brain Disease (1994)
-
Ornithine carbamoyl transferase deficiency: Findings, models and problems
Journal of Inherited Metabolic Disease (1992)